First clinical investigation to predict lymphovascular and/or perineural invasion in gastric cancer using 18F-FAPI-42 PET/CT parameters
- PMID: 40387910
- DOI: 10.1007/s00259-025-07325-9
First clinical investigation to predict lymphovascular and/or perineural invasion in gastric cancer using 18F-FAPI-42 PET/CT parameters
Abstract
Objective: This study was conducted to explore the predictive value of PET parameters derived from 18F-FAPI-42 PET/CT in assessing lymphovascular and/or perineural invasion (LVI/PNI) in gastric cancer (GC) patients.
Methods: 72 GC patients who underwent 18F-FAPI-42 PET/CT prior to surgical resection were included. Clinicopathological factors and PET parameters were collected and analyzed in LVI/PNI-negative and LVI/PNI-positive groups. The predictive value of PET parameters for LVI/PNI status was evaluated using the receiver operating characteristic (ROC) curve. A nomogram was developed using significant predictors from multivariate stepwise regression analysis and its performance was assessed by decision curve analysis (DCA).
Results: Univariate analysis indicated a significant association between LVI/PNI status and PET parameters (SUVmax, SUVmean, and TBR) (all p < 0.001). The area under the ROC curve (AUC) values for predicting LVI/PNI were 0.932 [95% CI (0.877-0.987)] for SUVmax, 0.923 [95% CI (0.861-0.984)] for SUVmean, and 0.925 [95% CI (0.865-0.985)] for TBR. The optimal cutoff values for prediction, along with their corresponding sensitivity and specificity, were 3.86 (93.3% and 81.5%) for SUVmax, 2.04 (93.3% and 81.5%) for SUVmean, and 9.75 (91.1% and 81.5%) for TBR. Multivariate analysis identified histological grade and SUVmax as independent risk factors for LVI/PNI prediction. Our nomogram had good discriminatory ability (AUC = 0.934) and offered net benefits in predicting LVI/PNI status by DCA.
Conclusion: This study demonstrates that FAPI uptake parameters exhibit an exceptionally high capacity and serve as a noninvasive preoperative tool for predicting LVI/PNI status in GC, with SUVmax emerging as the most suitable predictive indicator.
Keywords: Fibroblast activating protein inhibitor; Gastric cancer; Lymphovascular invasion; Perineural invasion; Positron emission tomography.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: All procedures in this study were performed in accordance with the ethics standards of the Helsinki Declaration. The study was approved by the Chinese Ethics Committee of Registering Clinical Trials (ChiECRCT20210617). Consent to participate: Informed consent was obtained from all participants included in this study. Consent for publication: All the authors approved the publication of this article. Competing interests: All authors declare that they have no commercial or financial interest.
Similar articles
-
Preoperative prediction of lymphovascular and perineural invasion in gastric cancer using spectral computed tomography imaging and machine learning.World J Gastroenterol. 2024 Feb 14;30(6):542-555. doi: 10.3748/wjg.v30.i6.542. World J Gastroenterol. 2024. PMID: 38463023 Free PMC article.
-
Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):217-230. doi: 10.1007/s00259-020-04747-5. Epub 2020 May 25. Eur J Nucl Med Mol Imaging. 2021. PMID: 32451603
-
Combination of single-source dual-energy computed tomography (CT) parameters and extracellular volume fraction for predicting lymphovascular and perineural invasion in colorectal cancer.Quant Imaging Med Surg. 2024 Oct 1;14(10):7524-7539. doi: 10.21037/qims-24-76. Epub 2024 Sep 26. Quant Imaging Med Surg. 2024. PMID: 39429592 Free PMC article.
-
Predictive performance of [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT) in evaluating response of recurrent or metastatic gastrointestinal stromal tumors: complementary or alternative to [18F]fluorodeoxyglucose (FDG) PET/CT?Quant Imaging Med Surg. 2024 Aug 1;14(8):5333-5345. doi: 10.21037/qims-24-192. Epub 2024 Jun 21. Quant Imaging Med Surg. 2024. PMID: 39144061 Free PMC article.
-
Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.Theranostics. 2023 Aug 21;13(13):4694-4710. doi: 10.7150/thno.88335. eCollection 2023. Theranostics. 2023. PMID: 37649615 Free PMC article.
References
-
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74:229–63. https://doi.org/10.3322/caac.21834 . - DOI
-
- Zhang CD, Ning FL, Zeng XT, Dai DQ. Lymphovascular invasion as a predictor for lymph node metastasis and a prognostic factor in gastric cancer patients under 70 years of age: A retrospective analysis. Int J Surg (London England). 2018;53:214–20. https://doi.org/10.1016/j.ijsu.2018.03.073 . - DOI
-
- Liebl F, Demir IE, Mayer K, Schuster T, DʼHaese JG, Becker K et al. The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological study. Annals of surgery. 2014;260:900-7; discussion 7–8. https://doi.org/10.1097/sla.0000000000000968
-
- Wu L, Liang Y, Zhang C, Wang X, Ding X, Huang C, et al., et al. Prognostic significance of lymphovascular infiltration in overall survival of gastric cancer patients after surgery with curative intent. Chin J cancer Res = Chung-kuo Yen Cheng Yen Chiu. 2019;31:785–96. https://doi.org/10.21147/j.issn.1000-9604.2019.05.08 . - DOI - PubMed
-
- Araki I, Hosoda K, Yamashita K, Katada N, Sakuramoto S, Moriya H, et al. Prognostic impact of venous invasion in stage IB node-negative gastric cancer. Gastric Cancer: Official J Int Gastric Cancer Association Japanese Gastric Cancer Association. 2015;18:297–305. https://doi.org/10.1007/s10120-014-0362-2 . - DOI
Grants and funding
- 2022A1515110051/Guangdong Basic and Applied Basic Research Foundation
- 2024A1515010124/Guangdong Basic and Applied Basic Research Foundation
- GZ2024YLJ035/Ganzhou Municipal Science and Technology Project
- 2021C021/President Foundation of Nanfang Hospital, Southern Medical University
- 2023A028/President Foundation of Nanfang Hospital, Southern Medical University
LinkOut - more resources
Full Text Sources
Miscellaneous